Enjoy complimentary customisation on priority with our Enterprise License!
The Preclinical Software for Physiology Data Assessment and Animal Supervision Market size is forecast to increase by USD 3.92 billion, at a CAGR of 5.62% between 2023 and 2028.
There has been an increasing awareness of physiological monitoring in preclinical research across the globe. In addition, in preclinical research, laboratory animals are considered a valuable resource. Moreover, the use of small animal subjects, such as rats and mice, as surgical models for biomedical research involves a substantial financial investment as well as time. Furthermore, scientists who have adequate resources to work with animal subjects have to accept the responsibility for ethical considerations. In addition, it is important to undertake all possible measures for achieving the maximum success rate with proper accuracy while simultaneously ensuring the safety and welfare of these animal subjects. Hence, such factors are positively impacting the market growth.
Technavio has segmented the market into End-user, Deployment, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The industrial labs and CROs segment is estimated to witness significant growth during the forecast period. Several pharmaceutical and biotechnology companies have developed the infrastructure needed to conduct preclinical and clinical studies for testing their drug candidates. However, various companies also outsource their preclinical research requirements to CROs to gain cost savings as well as to get access to a broad range of equipment and laboratory facilities, including preclinical software.
Get a glance at the market contribution of various segments Download PDF Sample
The industrial labs and CROs segment was the largest segment and was valued at USD 6.50 billion in 2018. Moreover, CROs can perform research activities that range from basic research to late-stage development, including R&D tasks, such as genetic engineering, safety and efficacy testing in animal models, hit exploration and lead optimization, assay development, target validation, as well as clinical trials involving people. In addition, biopharmaceutical companies have also increased their dependence on CROs for services in areas of preclinical and clinical research and drug discovery due to the high pressure that they face for improved R&D productivity. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
The on-premises deployment model offers a localized and secure solution for research facilities. In addition, in this model, the software is installed and operates within the organization's own computing infrastructure. For instance, ADInstruments Pty Ltd. provides a suite of software solutions, including LabChart, that enables researchers to collect and analyze physiological data in real time. Furthermore, the on-premises model ensures data security, compliance with regulatory standards, and customization based on the specific needs of research institutions and laboratories. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
The cloud deployment model comprises hosting software solutions on external servers managed by third-party software providers. In addition, the cloud operates over the internet, enabling users to access applications remotely without the need for on-premises infrastructure. Moreover, this model facilitates collaborative research efforts, as data can be securely stored and accessed from various locations, streamlining real-time collaboration and analysis of physiological data. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The leading position of North America in biomedical research and technological innovation is a primary catalyst, with prominent research institutions, academic centers, and pharmaceutical companies demanding advanced software solutions. In addition, government initiatives, particularly substantial funding from agencies such as the National Institutes of Health (NIH), contribute significantly, enabling the adoption of cutting-edge preclinical software technologies. Moreover, North America's stringent regulatory environment emphasizes the need for sophisticated software tools to ensure compliance and data integrity in preclinical studies. In addition, in North America, a significant number of people suffer from chronic diseases, such as cancer, asthma, COPD, and Alzheimer's disease, among others. Therefore, this has led to a substantial demand for scientific research as well as drug discovery and development, which, in turn, has resulted in a rapid rise in R&D expenditure on related research. Hence, such factors are driving market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 19 market companies, including:
ADInstruments Pty Ltd: The company offers preclinical software for physiology data assessment and animal supervision such as LabChart and LabChart Lightning for physiological, biological, and biomedical research.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the market growth is the emerging role of bioinformatics tools and software in preclinical research. Bioinformatics tools and software play a major role in the development of drug development as well as drug discovery. In addition, in these applications, the research requires bioinformatics tools for several reasons, including for using preclinical data in secondary research, for managing data during clinical trials, and for expanding knowledge related to human disease and overall health.
Moreover, the emergence of novel technologies in areas such as proteomics, molecular dynamics simulation, molecular docking, and quantitative structure-activity relationships in clinical research facilitates and speeds up the drug discovery procedure. Furthermore, during the preclinical research stage, this software is extensively used for randomization in planning the study design and eliminating any bias. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the market growth is the rising digitalization in preclinical research. Preclinical research has become a crucial part of drug development and scientific research. However, taking manual readings may result in highly inaccurate results that might negatively impact the outcome of experiments. Therefore, the market is witnessing the advent of digitization in preclinical research.
Moreover, one of the major breakthroughs has been the ability to capture preclinical data electronically. In addition, for many years, companies worldwide have extensively used electronic data capture for data collection in clinical research settings. Furthermore, many software companies are developing tools that enable researchers and scientists to gather data electronically in preclinical studies. Hence, such factors are positively impacting the market which in turn drives the market growth during the forecast period.
Characteristic disadvantages of animal studies are one of the key challenges hindering market growth. Although animal subjects are considered useful and are extensively used in preclinical research, there are many characteristic disadvantages of animal studies. For instance, one of the major disadvantages that scientists face during preclinical research is the inability to replicate animal studies in human trials.
Moreover, this can be attributed to the poor design of the procedures in experiments, the choice of incorrect approaches while conducting the procedures in the lab environment, or the inaccurate analysis of the measurements. In addition, the small size of mice leads to challenges such as the lack of precision in assessing the mechanical response of the organs, due to which scientists have to compromise on the non-invasiveness of the experiment. Hence, such factors are hindering the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides a market research and growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028.
Preclinical Software for Physiology Data Assessment and Animal Supervision Market Scope |
|
Report Coverage |
Details |
Page number |
161 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.62% |
Market Growth 2024-2028 |
USD 3.92 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.89 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 44% |
Key countries |
US, UK, Germany, France, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology bv, PerkinElmer Inc, Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Vanderbilt University Medical Center, Xybion Digital Inc., and Zaber Technologies Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Deployment
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.